Patent · US Active

Formulation for soft anticholinergic analogs

US11052067B2 · kind B2 · utility

6Cited by

11References

29Claims

0Family size

Assignee

BODOR LABORATORIES, INC. · US

Inventors

Nicholas S. Bodor · Surfside, US
John J. Koleng · Austin, US
David Angulo · Miami, US

Key dates

Filing date	Nov 30, 2020
Grant date	Jul 6, 2021
Priority date	—
Expiry date	Nov 30, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.